1. INCLUSION OF A PEDIATRIC PERSPECTIVE INTO RECOMMENDATIONS FOR THE INITIAL EVALUATION AND STAGING OF HODGKIN LYMPHOMA: A CALL TO ACTION FROM THE INTERNATIONAL SEARCH WORKING GROUP. (12th June 2019) Authors: Flerlage, J.; Mauz‐Körholz, C.; Kelly, K.; McCarten, K.; Punnett, A.; Kaste, S.; Dieckmann, K.; Marks, L.; Seelisch, J.; Drachtman, R.; Lewis, J.; Beishuzen, A.; Kluge, R.; Kurch, L.; Stroevesandt, D.; Metzger, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAFETY AND RESPONSE AFTER 2 CYCLES OF BRENTUXIMAB VEDOTIN SUBSTITUTING VINCRISTINE IN THE OEPA/COPDAC REGIMEN FOR HIGH RISK PEDIATRIC HODGKIN LYMPHOMA (HL). (12th June 2019) Authors: Metzger, M.; Mauz‐Körholz, C.; Flerlage, J.; Bartelt, J.; Billett, A.; Choi, J.K.; Ehrhardt, M.; Georgi, T.; Hasenclever, D.; Wang, F.; Zhang, H.; Kaste, S.C.; Kluge, R.; Körholz, D.; Kurch, L.; Link, M.; Stoevesandt, D.; Hudson, M.M.; Krasin, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗